← Previous Post: | Next Post: →

 

“These days … medical research is not just a scholarly affair. It is also a global, multibillion-dollar business enterprise, powered by the pharmaceutical and medical-device industries. The ethical problem today is not merely that these corporations have plenty of money to grease the wheels of university research. It’s also that researchers themselves are often given powerful financial incentives to do unethical things: pressure vulnerable subjects to enroll in studies, fudge diagnoses to recruit otherwise ineligible subjects and keep subjects in studies even when they are doing poorly.”

UD‘s pal Carl Elliott tells all in a New York Times opinion piece.

Margaret Soltan, May 27, 2015 7:50AM
Posted in: merchandise

Trackback URL for this post:
https://www.margaretsoltan.com/wp-trackback.php?p=48562

One Response to ““These days … medical research is not just a scholarly affair. It is also a global, multibillion-dollar business enterprise, powered by the pharmaceutical and medical-device industries. The ethical problem today is not merely that these corporations have plenty of money to grease the wheels of university research. It’s also that researchers themselves are often given powerful financial incentives to do unethical things: pressure vulnerable subjects to enroll in studies, fudge diagnoses to recruit otherwise ineligible subjects and keep subjects in studies even when they are doing poorly.””

  1. Jack/OH Says:
    May 27th, 2015 at 8:36AM

    AMA, AHIP, Big Pharma, AHA, MDMA-America’s medico-actuarial Iron Pyramid. What’s astonishing is that so many reasonably intelligent people who benefit from the existing distribution of medical goods and services seem genuinely convinced they’re getting the goodies because Adam Smith’s free markets are workin’ their magic.

Comment on this Entry

Latest UD posts at IHE

Archives

Categories